HPV Vaccination May Cut Risk for CIN2+ Recurrence
FRIDAY, Aug. 5, 2022 -- Human papillomavirus (HPV) vaccination seems to reduce the risk for cervical intraepithelial neoplasia grade 2 or higher (CIN2+) recurrence, according to a review published online Aug. 3 in The BMJ.
Konstantinos S....
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cervical Cancer Vaccine | Genital Warts | Human Papillomavirus (HPV) | Pharmaceuticals | Vaccines